|
1
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang Y, Yang Q and Wang S: MicroRNAs: A
new key in lung cancer. Cancer Chemother Pharmacol. 74:1105–1111.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yin R, Guo L, Zhang W and Zheng J: The
pleiotropic effects of mirnas on tumor angiogenesis. J Cell
Biochem. 116:1807–1815. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ma L, Teruya-Feldstein J and Weinberg RA:
Tumour invasion and metastasis initiated by microRNA-10b in breast
cancer. Nature. 449:682–688. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hess KR, Varadhachary GR, Taylor SH, Wei
W, Raber MN, Lenzi R and Abbruzzese JL: Metastatic patterns in
adenocarcinoma. Cancer. 106:1624–1633. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
McIntyre A and Ganti AK: Lung cancer-A
global perspective. J Surg Oncol. 115:550–554. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cho WC: Role of miRNAs in lung cancer.
Expert Rev Mol Diagn. 9:773–776. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hashemi ZS, Khalili S, Forouzandeh
Moghadam M and Sadroddiny E: Lung cancer and miRNAs: A possible
remedy for anti-metastatic, therapeutic and diagnostic
applications. Expert Rev Respir Med. 11:147–157. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rusek AM, Abba M, Eljaszewicz A, Moniuszko
M, Niklinski J and Allgayer H: MicroRNA modulators of epigenetic
regulation, the tumor microenvironment and the immune system in
lung cancer. Mol Cancer. 14:342015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Johnson CD, Esquela-Kerscher A, Stefani G,
Byrom M, Kelnar K, Ovcharenko D, Wilson M, Wang X, Shelton J,
Shingara J, et al: The let-7 microRNA represses cell proliferation
pathways in human cells. Cancer Res. 67:7713–7722. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ntoumou E, Tzetis M, Braoudaki M, Lambrou
G, Poulou M, Malizos K, Stefanou N, Anastasopoulou L and Tsezou A:
Serum microRNA array analysis identifies miR-140-3p, miR-33b-3p and
miR-671-3p as potential osteoarthritis biomarkers involved in
metabolic processes. Clin Epigenetics. 9:1272017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xiong DD, Chen H, He RQ, Lan AH, Zhong JC,
Chen G, Feng ZB and Wei KL: MicroRNA-671-3p inhibits the
development of breast cancer: A study based on in vitro
experiments, in-house quantitative polymerase chain reaction and
bioinformatics analysis. Int J Oncol. 52:1801–1814. 2018.PubMed/NCBI
|
|
14
|
Chen MT, Sun HF, Li LD, Zhao Y, Yang LP,
Gao SP and Jin W: Downregulation of FOXP2 promotes breast cancer
migration and invasion through TGFβ/SMAD signaling pathway. Oncol
Lett. 15:8582–8588. 2018.PubMed/NCBI
|
|
15
|
Jia WZ, Yu T, An Q, Yang H, Zhang Z, Liu X
and Xiao G: MicroRNA-190 regulates FOXP2 genes in human gastric
cancer. Onco Targets Ther. 9:3643–3651. 2016.PubMed/NCBI
|
|
16
|
Cuiffo BG, Campagne A, Bell GW, Lembo A,
Orso F, Lien EC, Bhasin MK, Raimo M, Hanson SE, Marusyk A, et al:
MSC-regulated microRNAs converge on the transcription factor FOXP2
and promote breast cancer metastasis. Cell Stem Cell. 15:762–774.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yu Z, Lin X, Tian M and Chang W:
microRNA-196b promotes cell migration and invasion by targeting
FOXP2 in hepatocellular carcinoma. Oncol Rep. 39:731–738.
2018.PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen X, Lu P, Wang DD, Yang SJ, Wu Y, Shen
HY, Zhong SL, Zhao JH and Tang JH: The role of miRNAs in drug
resistance and prognosis of breast cancer formalin-fixed
paraffin-embedded tissues. Gene. 595:221–226. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jiménez MJ, Balbin M, Alvarez J, Komori T,
Bianco P, Holmbeck K, Birkedal-Hansen H, López JM and López-Otín C:
A regulatory cascade involving retinoic acid, Cbfa1, and matrix
metalloproteinases is coupled to the development of a process of
perichondrial invasion and osteogenic differentiation during bone
formation. J Cell Biol. 155:1333–1344. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Khokha R and Denhardt DT: Matrix
metalloproteinases and tissue inhibitor of metalloproteinases: A
review of their role in tumorigenesis and tissue invasion. Invasion
Metastasis. 9:391–405. 1989.PubMed/NCBI
|
|
23
|
Tan W, Liu B, Qu S, Liang G, Luo W and
Gong C: MicroRNAs and cancer: Key paradigms in molecular therapy.
Oncol Lett. 15:2735–2742. 2018.PubMed/NCBI
|
|
24
|
Yang Y, Ding L, Hu Q, Xia J, Sun J, Wang
X, Xiong H, Gurbani D, Li L, Liu Y and Liu A: MicroRNA-218
functions as a tumor suppressor in lung cancer by targeting
IL-6/STAT3 and negatively correlates with poor prognosis. Mol
Cancer. 16:1412017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang Y, Li H, Liu Y, Chi C, Ni J and Lin
X: miR-4319 hinders YAP expression to restrain non-small cell lung
cancer growth through regulation of LIN28-mediated RFX5 stability.
Biomed Pharmacother. 115:1089562019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tan X, Fu Y, Chen L, Lee W, Lai Y Rezaei
K, Tabbara S, Latham P, Teal CB, Man YG, et al: miR-671-5p inhibits
epithelial-to-mesenchymal transition by downregulating FOXM1
expression in breast cancer. Oncotarget. 7:293–307. 2016.PubMed/NCBI
|
|
27
|
Chiu YC, Li MY, Liu YH, Ding JY, Yu JY and
Wang TW: Foxp2 regulates neuronal differentiation and neuronal
subtype specification. Dev Neurobiol. 74:723–738. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Katoh M and Katoh M: Human FOX gene family
(Review). Int J Oncol. 25:1495–1500. 2004.PubMed/NCBI
|
|
29
|
Tsui D, Vessey JP, Tomita H, Kaplan DR and
Miller FD: FoxP2 regulates neurogenesis during embryonic cortical
development. J Neurosci. 33:244–258. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Enard W, Przeworski M, Fisher SE, Lai CS,
Wiebe V, Kitano T, Monaco AP and Pääbo S: Molecular evolution of
FOXP2, a gene involved in speech and language. Nature. 418:869–872.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Herrero MJ and Gitton Y: The untold
stories of the speech gene, the FOXP2 cancer gene. Genes Cancer.
9:11–38. 2018.PubMed/NCBI
|
|
32
|
Campbell AJ, Lyne L, Brown PJ, Launchbury
RJ, Bignone P, Chi J, Roncador G, Lawrie CH, Gatter KC, Kusec R and
Banham AH: Aberrant expression of the neuronal transcription factor
FOXP2 in neoplastic plasma cells. Br J Haematol. 149:221–230. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yan X, Zhou H and Zhang T, Xu P, Zhang S,
Huang W, Yang L, Gu X, Ni R and Zhang T: Downregulation of FOXP2
promoter human hepatocellular carcinoma cell invasion. Tumour Biol.
36:9611–9619. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Song XL, Tang Y, Lei XH, Zhao SC and Wu
ZQ: miR-618 inhibits prostate cancer migration and invasion by
targeting FOXP2. J Cancer. 8:2501–2510. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen MT, Sun HF, Li LD, Zhao Y, Yang LP,
Gao SP and Jin W: Downregulation of FOXP2 promotes breast cancer
migration and invasion through TGFβ/SMAD signaling pathway. Oncol
Lett. 15:8582–8588. 2018.PubMed/NCBI
|
|
36
|
Cuiffo BG and Karnoub AE: Silencing FOXP2
in breast cancer cells promotes cancer stem cell traits and
metastasis. Mol Cell Oncol. 3:e10190222015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wu J, Liu P, Tang H, Shuang Z, Qiu Q,
Zhang L, Song C, Liu L, Xie X and Xiao X: FOXP2 Promotes tumor
proliferation and metastasis by targeting GRP78 in triple-negative
breast cancer. Curr Cancer Drug Targets. 18:382–389. 2018.
View Article : Google Scholar : PubMed/NCBI
|
